Filing of Investigational New Drug application
(World News Science)

Tiziana Life Sciences plc (the `Company` or `Tiziana Life Sciences`) Filing of Investigational New Drug application Tiziana Life Sciences plc (AIM: TILS), a UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, is pleased to announce submission of an Investigational New Drug (`IND`) application to the U.S. Food and Drug Administration in collaboration with the Brigham and Women`s Hospital, Harvard Medical School, Boston, MA (`BWH`) to Initiate Phase 1 Clinical Trials with Foralumab, to be administered nasally to healthy volunteers, with the objective of demonstrating proof of concept in a potentially...